M&A Deal Summary

Castle Creek Biosciences Acquires Novavita Thera

On January 10, 2022, Castle Creek Biosciences acquired life science company Novavita Thera

Acquisition Highlights
  • This is Castle Creek Biosciences’ 1st transaction in the Life Science sector.
  • This is Castle Creek Biosciences’ 1st transaction in the United States.
  • This is Castle Creek Biosciences’ 1st transaction in Minnesota.

M&A Deal Summary
Date 2022-01-10
Target Novavita Thera
Sector Life Science
Buyer(s) Castle Creek Biosciences
Deal Type Add-on Acquisition

Target

Novavita Thera

Rochester, Minnesota, United States
Novavita Thera is a preclinical gene therapy company focused on rare liver and metabolic diseases. Novavita Thera is based in Rochester, Minnesota.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Castle Creek Biosciences

Exton, Pennsylvania, United States
Category Company
Sector Life Science
DESCRIPTION

Castle Creek Biosciences is a late-clinical stage cell and gene therapy company focused on developing and preparing to commercialize disease-modifying and potentially curative therapies for patients living with rare genetic diseases. Castle Creek Biosciences is based in Exton, Pennsylvania.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Minnesota) 1 of 1
Country (United States) 1 of 1
Year (2022) 1 of 1
Mergr

Product

Company

Legal